跳至主要内容
临床试验/NCT06624800
NCT06624800招募中不适用

The Efficacy and Safety of Shoulder Chuna on in Patients with Shoulder Pain Caused by Traffic Accidents: a Pragmatic Randomized Controlled Trial

Jaseng Medical Foundation1 个研究点 分布在 1 个国家目标入组 98 人开始时间: 2024年11月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
98
试验地点
1
主要终点
Numeric Rating Scale(NRS) of Shoulder pain

研究概览

简要总结

This study is a double blind, randomized controlled trail. condition/disease: Patient with acute shoulder pain and restricted movement due to a traffic accident. treatment/intervention: Chuna therapy for the shoulder, including integrated Korean medicine treatment

详细描述

The investigators intend to conduct a randomized controlled trial to evaluate the effectiveness of Chuna therapy for shoulder pain and restricted movement caused by a traffic accident. The study will involve administering shoulder Chuna therapy from the second day of hospitalization until discharge, with the aim of assessing its effects on shoulder pain relief and recovery of range of motion. Although the effectiveness of Korean medicine for treating trauma from traffic accidents has been well studied, the research has largely focused on spinal conditions, such as those affecting the cervical and lumbar spine. Likewise, most studies on Chuna therapy have centered around spinal disorders. Through this study, the investigators aim to explore the therapeutic effects of shoulder Chuna therapy, an area that has not been extensively researched.

  1. The effectiveness of shoulder Chuna therapy will be evaluated by observing and comparing changes in pain, range of motion limitation, functional disability, quality of life, and patient satisfaction between the shoulder Chuna group (treatment group) and the Korean integrative medicine group (control group).
  2. Investigators will assess the treatment effects of shoulder Chuna therapy on shoulder pain and restricted movement by observing improvements in initial NRS, VAS scores, SPADI, and ROM in the shoulder Chuna group (treatment group) compared to the Korean integrative medicine group (control group).
  3. The total number of treatment sessions and the degree of improvement will be observed and compared between the shoulder Chuna group (treatment group) and the Korean integrative medicine group (control group) to evaluate the effectiveness of the treatment frequency.
  4. The safety of the therapy will be assessed by investigating adverse reactions in both the shoulder Chuna group (treatment group) and the Korean integrative medicine group (control group).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients aged 19-69 years on the date they sign the consent form.
  • •Patients with shoulder pain and restricted movement occurring within 5 days after a traffic accident.
  • •Patients who are hospitalized due to traffic accident.
  • •Patients with NRS of shoulder pain ≥ 5 with restricted movement due to a traffic accident.
  • •Patients who provide consent to participate in the trial and return the informed consent form.

排除标准

  • •Patients with a specific serious disease that may cause shoulder pain: malignancy, spondylitis, inflammatory spondylitis, etc.
  • •Patients with progressive neurological deficits or with severe neurological symptoms.
  • •Patients with medical history of cervical surgery or shoulder surgery within the last three weeks.
  • •Patients with a specific serious disease that may interfere with the interpretation of the therapeutic effects or results: malignancy, spondylitis, inflammatory spondylitis, etc.
  • •Chuna therapy is deemed inappropriate or unsafe due to conditions like fractures, dislocations, ligament tears, or unstable healing fractures; skeletal demineralization and ligament laxity with subluxation or dislocation; or inflammation
  • •Presence of other chronic diseases that could interfere with treatment outcomes or interpretation, such as cardiovascular disease, kidney disease, diabetic neuropathy, dementia, or epilepsy
  • •Currently taking steroids, immunosuppressants, psychiatric medications, or other drugs that may affect study results
  • •Acupuncture is deemed inappropriate or unsafe, such as in patients with bleeding disorders, those on anticoagulant therapy, those with severe diabetes prone to infection, or those with severe cardiovascular disease
  • •Patients who are pregnant or planning to become pregnant.
  • •Patients who are presence of severe mental illness
  • •Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
  • •Patients who are difficult to complete the research participation agreement.
  • •Other patients whose participation in the trial is judged by a researcher to be problematic.

研究组 & 干预措施

Shoulder chuna treatment

Experimental

During the hospitalization period, Chuna therapy for the shoulder joint will be performed once a day for a total of 10 to 15 minutes, including before, during, and after the treatment. The practitioner will assess the condition and select one of three techniques-posterior displacement, anterior displacement, or lateral displacement-to apply Chuna therapy

干预措施: Korean medical treatment (Procedure)

Korean medical treatment

Active Comparator

The control group were received Korean medical treatment everyday after hospitalization: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.

干预措施: Shoulder chuna treatment(posterior displacement, anterior displacement, or lateral displacement) (Procedure)

Korean medical treatment

Active Comparator

The control group were received Korean medical treatment everyday after hospitalization: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.

干预措施: Korean medical treatment (Procedure)

结局指标

主要结局

Numeric Rating Scale(NRS) of Shoulder pain

时间窗: Screening, From baseline(Day2) up to Discharge 1 day, 2week after enrollment, 1month after enrollment, 3month after enrollment

NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participant is asked to report their shoulder pain and discomfort using NRS, where 0 indicates \'no pain or discomfort\' and 10 indicates \'the most severe pain and discomfort imaginable\'.

次要结局

  • Location of shoulder joint displacement(Screening, From baseline(Day2) up to Discharge 1 day, 2week after enrollment, 1month after enrollment, 3month after enrollment)
  • Shoulder Pain intensity scale: Visual Analogue Scale (VAS)(From baseline(Day2) up to Discharge 1 day)
  • Physical examination (Shoulder active range of motion)(From baseline(Day2) up to Discharge 1 day)
  • Shoulder Pain and Disability Index(SPADI)(From baseline(Day2) up to Discharge 1 day, 2week after enrollment, 1month after enrollment, 3month after enrollment)
  • EuroQol 5-Dimension (EQ-5D)(From baseline(Day2) up to Discharge 1 day, 2week after enrollment, 1month after enrollment, 3month after enrollment)
  • Patient Global Impression of Change (PGIC)(Discharge 1 day, 2week after enrollment, 1month after enrollment, 3month after enrollment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验